Intelligent Bio Solutions Inc. develops rapid, non-invasive medical testing technology, best known for a fingerprint-sweat drug screening system that collects samples in seconds and produces results in under ten minutes. The Nasdaq-listed company also distributes a wearable sweat patch for continuous drug monitoring over seven to ten days, extending its testing approach from immediate workplace screening to longer-term justice and rehabilitation settings. Its products are sold in 35 countries and territories through more than 480 active customer accounts, with manufacturing and quality operations managed to ISO 9001 and ISO 13485 standards.
ISO 9001
ISO 13485
NATA Accreditation of Laboratory Partner RASL
Intelligent Fingerprinting LtdFounded in 2007 from chemistry research at the University of East Anglia, Intelligent Fingerprinting develops and manufactures rapid workplace drug-screening systems that analyse sweat from the fingertips. Its Cambridge team makes the single-use screening cartridges in-house and pairs them with a portable reader, producing results in about ten minutes without collecting fingerprints or requiring specialist facilities. The company is now a wholly owned subsidiary of Intelligent Bio Solutions Inc. and serves more than 480 customers worldwide.New York, NY
Chembio Diagnostic Systems, IncChembio Diagnostic Systems, a Medford, New York subsidiary of Biosynex, develops and manufactures rapid point-of-care diagnostic tests for detecting and monitoring disease. Its proprietary Dual Path Platform (DPP®) technology supports simple tests that can use a small blood sample and deliver results in about 15 minutes, including the FDA-approved, CLIA-waived DPP® HIV-Syphilis test. Chembio serves clients worldwide through offices and partners and also applies its diagnostic platform to veterinary testing.MEDFORD, NY
OraSure Technologies, IncFounded in 1987 as SolarCare in Bethlehem, OraSure Technologies develops and manufactures non-invasive rapid diagnostic tests and biological-sample collection devices. Now headquartered in Bethlehem and publicly traded since 2000, the company is known for point-of-care testing that brings HIV, HCV and other infectious-disease results closer to patients, alongside DNA Genotek sample-management solutions for genomic and microbiome research. Its OraQuick platform includes the first FDA-approved, CLIA-waived rapid HCV test and an oral-fluid HIV self-test.325413BETHLEHEM, PA
AllSource Screening SolutionsFounded in 2009, Pennsylvania-based AllSource Screening Solutions manufactures and distributes diagnostic testing products, with its roots in drug-screening kits developed through the owners’ staffing-agency work. The company now supplies testing products worldwide and has developed what it describes as the first FDA-cleared, OTC-approved and CLIA-waived fentanyl dip-card test in the United States. Its retail Drug Detector line extends that screening focus to at-home consumers and pharmacies.325413EXPORT, PA